These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 1696557

  • 1. [The prognostic application of thyroid volume determination in patients with Graves' disease].
    Sakane S.
    Nihon Naibunpi Gakkai Zasshi; 1990 May 20; 66(5):543-56. PubMed ID: 1696557
    [Abstract] [Full Text] [Related]

  • 2. Change of circulating thyroid autoantibody titers in Graves' hyperthyroidism after antithyroid drugs therapy.
    Lin HD, Tai FT, Chen HD, Lee SP, Chang FY, Wang GG, Tang KT, Lee JK.
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Feb 20; 47(2):86-90. PubMed ID: 1705860
    [Abstract] [Full Text] [Related]

  • 3. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
    Komaki T, Sakata S, Nakamura S, Matsuda M, Kojima N, Takuno H, Miura K.
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul 20; 65(7):627-39. PubMed ID: 2583311
    [Abstract] [Full Text] [Related]

  • 4. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A.
    Thyroid; 2000 Oct 20; 10(10):891-6. PubMed ID: 11081255
    [Abstract] [Full Text] [Related]

  • 5. Changes in thyroid volume during antithyroid drug therapy for Graves' disease and its relationship to TSH receptor antibodies, TSH and thyroglobulin.
    Yamaguchi Y, Inukai T, Iwashita A, Nishino M, Yamaguchi T, Shohda Y, Shimomura Y, Ohshima K, Kobayashi S, Kobayashi I.
    Acta Endocrinol (Copenh); 1990 Oct 20; 123(4):411-5. PubMed ID: 1978459
    [Abstract] [Full Text] [Related]

  • 6. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
    Choo YK, Yoo WS, Kim DW, Chung HK.
    Thyroid; 2010 Sep 20; 20(9):949-54. PubMed ID: 20629556
    [Abstract] [Full Text] [Related]

  • 7. Changes in serum thyroglobulin and thyroid autoantibodies in patients with Graves' disease treated with antithyroid drug and their relationship to relapse.
    Gong ST, Chao IM.
    J Formos Med Assoc; 1991 Dec 20; 90(12):1155-62. PubMed ID: 1724781
    [Abstract] [Full Text] [Related]

  • 8. Effect of thyroxine administration on serum thyrotropin receptor antibody and thyroglobulin levels in patients with Graves' hyperthyroidism during antithyroid drug therapy.
    Kuo SW, Huang WS, Hu CA, Liao WK, Fung TC, Wu SY.
    Eur J Endocrinol; 1994 Aug 20; 131(2):125-30. PubMed ID: 8075781
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
    Izumi Y, Takeoka K, Amino N.
    Endocr J; 2005 Aug 20; 52(4):493-7. PubMed ID: 16127219
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study.
    Cappelli C, Gandossi E, Castellano M, Pizzocaro C, Agosti B, Delbarba A, Pirola I, De Martino E, Rosei EA.
    Endocr J; 2007 Dec 20; 54(5):713-20. PubMed ID: 17675761
    [Abstract] [Full Text] [Related]

  • 11. Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene.
    Kinjo Y, Takasu N, Komiya I, Tomoyose T, Takara M, Kouki T, Shimajiri Y, Yabiku K, Yoshimura H.
    J Clin Endocrinol Metab; 2002 Jun 20; 87(6):2593-6. PubMed ID: 12050220
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
    Glinoer D, de Nayer P, Bex M, Belgian Collaborative Study Group on Graves' Disease.
    Eur J Endocrinol; 2001 May 20; 144(5):475-83. PubMed ID: 11331213
    [Abstract] [Full Text] [Related]

  • 14. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D, Massart C.
    Clin Endocrinol (Oxf); 2001 Jan 20; 54(1):89-96. PubMed ID: 11167931
    [Abstract] [Full Text] [Related]

  • 15. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K.
    J Endocrinol Invest; 1997 Sep 20; 20(8):452-61. PubMed ID: 9364248
    [Abstract] [Full Text] [Related]

  • 16. A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment.
    Giuliani C, Cerrone D, Harii N, Thornton M, Kohn LD, Dagia NM, Bucci I, Carpentieri M, Di Nenno B, Di Blasio A, Vitti P, Monaco F, Napolitano G.
    J Clin Endocrinol Metab; 2012 Jul 20; 97(7):E1080-7. PubMed ID: 22492869
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
    Nakazato N, Yoshida K, Mori K, Kiso Y, Sayama N, Tani JI, Nakagawa Y, Ito S.
    Thyroid; 1999 Aug 20; 9(8):775-9. PubMed ID: 10482369
    [Abstract] [Full Text] [Related]

  • 19. [Long-term follow up after antithyroid drug treatment in Graves' disease].
    Wille T, Müller B, Noth D, Bürgi U, Diem P.
    Praxis (Bern 1994); 2006 Jul 19; 95(29-30):1121-7. PubMed ID: 16916174
    [Abstract] [Full Text] [Related]

  • 20. The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease.
    Fukao A, Takamatsu J, Murakami Y, Sakane S, Miyauchi A, Kuma K, Hayashi S, Hanafusa T.
    Clin Endocrinol (Oxf); 2003 May 19; 58(5):550-5. PubMed ID: 12699435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.